About EurexOTC Clear
EMIR 3.0 - active account
CCP Switch
On-boarding
Compression Service
Product Scope
Interest Rate Swaps
Inflation Swaps
Settlement Prices
Service Offering for PSAs
Clearing Member
ISA Direct Member
ISA Direct Light Licence Holder
Clearing Agent
Client
Jurisdictions
Multiple Clearing Relationships
Segregation Set up
Cross-Project-Calendar
Readiness for projects
C7 Releases
C7 SCS Releases
C7 CAS Releases
EurexOTC Clear Releases
Prisma Releases
Member Section Releases
Simulation calendar
Archive
User ID Maintenance
Clearing Hours
Clearing Reports
Product Specifications
Clearing on behalf
Delivery Management
Transaction Management
Collateral Management
Collateral
Transparency Enabler Files
Segregation Models
Reports
Default Fund
Intraday Margin Calls
OTC Clear Procedures
OTC Clear Tutorials
Cross Margining Support
Supplementary Margins
Default Waterfall
Model Validation
Stress testing
Default Management Process
Client Asset Protection under EMIR
Client Asset Protection under LSOC
Credit, concentration & wrong way risk
System-based risk controls
Pioneering CCP Transparency
Haircut and adjusted exchange rates
Securities margin groups and classes
Prices Rolling Spot Future
File services
Bond Clusters
Listed derivatives
OTC derivatives
Listed securities
Cash management
Delivery management
CCP eligible instruments
Eurex Newsletter Subscription
Circulars & Newsflashes Subscription
Corporate Action Information Subscription
Circulars & Readiness Newsflashes
News
Videos
Webcasts on demand
Publications
Forms
Events
FAQs
Production Newsboard
Eurex
November was characterized by post-election and vaccine-driven bullish sentiment propelling the global equity markets. The subsequent burst of activity saw several Eurex products trade heavily, especially the benchmark EURO STOXX 50® and STOXX® Europe 600, where both the futures and options leaped-up in volumes compared to the same month last year.
The market entered a great sector rotation: Before the vaccine news emerged, technology firms had been the best-performers. At the same time, investors were naturally defensive in other sectors, such as consumer staples and utilities. Last month we saw these same investors moving aggressively into cyclical sectors such as energy, transportation, and financials. Consequently, we saw record volumes in the Bank sector suite of index futures, options and dividend futures. Market participants expect a recovery in dividends as corporate earnings grow and regulator guidance eases to facilitate a resumption of shareholder cash payments. Several other STOXX® Europe 600 sectors also experienced robust volumes in both futures and options: Oil & Gas, Telecoms, Basic Resources, Insurance, Autos & Parts, Utilities, Travel & Leisure and also Industrial Goods & Services.
This positive shift in market positioning also drove index derivative activity at a global level. MSCI futures in focus included, at a regional level: EM Asia, World, Europe, EM Latam and Pacific. Also, at a country level: Japan, Australia, Canada, India, China Free, Thailand and Malaysia. Additionally, two of the recent MSCI EM index inclusions, namely Saudi Arabia and Kuwait, continued to experience a solid level of interest. All of this bodes well for the December roll period, where we anticipate our members and clients will heavily utilize the Eurex order books to extend their positioning into 2021.
After the December expiry, members can look forward to the recalibration of tick sizes for our DAX® Futures. Here the tick size will increase while our Banks sector futures will see tick size reductions. The purpose is to improve liquidity and customer experience by re-aligning both these contract parameters given the divergent spot price moves during recent years.
Zubin Ramdarshan, Head of Equity & Index Product Design, Eurex